First British Volunteer Receives Experimental Ebola Vaccine
News outlets report on the announcement that the first British volunteer was injected this week with an experimental Ebola vaccine, made by GlaxoSmithKline and the U.S. National Institutes of Health.
Associated Press: 1st U.K. volunteer gets experimental Ebola vaccine
“British scientists say a former nurse has become the first person in the country to receive an experimental Ebola vaccine in an early trial to test its safety…” (9/17).
The Guardian: First British volunteer injected with trial Ebola vaccine in Oxford
“A woman in Oxford has become the first British volunteer to be injected with an experimental Ebola vaccine, which, if it works, will be fast-tracked for use in West Africa…” (Boseley, 9/17).
Financial Times: Oxford volunteer given experimental vaccine against Ebola
“…Ruth Atkins, 48, was injected with the candidate Ebola vaccine on Wednesday after a clinical assessment. She was the first of 60 volunteers to participate in the trial…” (Cookson, 9/17).
Huffington Post: First Volunteer Receives Potential Ebola Vaccine In Safety Trial
“A 48-year-old communications and engagement manager in the U.K.’s National Health Service became the first volunteer to receive a candidate Ebola vaccine today in a safety trial. The vaccine is currently being developed by GlaxoSmithKline and the U.S. National Institutes of Health…” (Chan, 9/17).
Reuters: First U.K. volunteer gets experimental GSK Ebola shot in trial
“The first volunteer in a fast-tracked British safety trial of an experimental Ebola vaccine made by GlaxoSmithKline received the injection on Wednesday, trial organizers said…” (Kelland, 9/17).
Washington Post: British volunteer receives Ebola vaccine in second human trial
“…In a statement, Atkins said that she felt ‘absolutely fine’ after receiving what is currently known as the NIAID/GSK vaccine, after the National Institute of Allergy and Infectious Diseases and the pharmaceutical company GlaxoSmithKline…” (Phillip, 9/17).